מן הרשת 06.03.202512:37 Early Disease-Modifying Treatments for Presymptomatic Multiple Sclerosis Discussing each RIS case with an expert MS team is recommended because there is still a lack of clinical guidelines to improve care, counseling, and surveillance CNS Drugs
מן הרשת 06.03.202512:36 Management of multiple sclerosis in older adults review of current evidence and future perspectives Journal of Neurology
מן הרשת 05.03.202513:59 Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease Is sex associated with rate of regional tau accumulation in adults without cognitive impairment at baseline? JAMA Neurology
מן הרשת 26.01.202511:04 הבדלי מין ומגדר בחשיפה לאלימות במהלך הילדות והשפעתה בבגרות על תחלואה גופנית כרונית לאלימות ולהתעללות כלפי ילדים יש השפעה ארוכת טווח על בריאות הגוף והנפש. בעוד שהקשר לבריאות הנפש אינטואיטיבי למדי, בשנים האחרונות מתחוור הקשר שבין פגיעה בגיל ילדות לבין עלייה בתחלואה גופנית כרונית בבגרות. בסקירה זו ביקשנו להביט על קשר זה דרך עדשה מגדרית לנה אבייב, ענבל מנדלר, ליאור ברוך, הרפואה
מן הרשת 22.01.202512:42 Datopotamab Deruxtecan in Advanced or Metastatic NSCLC With Actionable Genomic Alterations Results From the Phase II TROPION-Lung05 Study Journal of Clinical Oncology
מן הרשת 22.01.202512:40 Tyrosine Kinase Inhibitors for Brain Metastases Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene–Driven Non–Small Cell Lung Cancer (TURBO-NSCLC) Journal of Clinical Oncology
מן הרשת 22.01.202512:39 Subcutaneous Versus Intravenous Amivantamab Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study Journal of Clinical Oncology
מן הרשת 22.01.202512:38 Pemetrexed and Platinum for NSCLC Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR–Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer Journal of Clinical Oncology
מן הרשת 22.01.202512:36 Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations ASCO Living Guideline, Version 2024.2 Journal of Clinical Oncology
מן הרשת 22.01.202512:35 TERT Expression and Clinical Outcome in Pulmonary Carcinoids We investigated whether TERT expression defines the clinical fate of patients with pulmonary carcinoid Journal of Clinical Oncology
מן הרשת 22.01.202512:34 Systemic Therapy for Small Cell Lung Cancer ASCO Guideline Rapid Recommendation Update Journal of Clinical Oncology
מן הרשת 22.01.202512:33 Body Weight Gain Associated With Alectinib in Patients With ALK+ NSCLC Pooled Analysis of Individual Patient Data From Four Prospective Clinical Trials Journal of Clinical Oncology
מן הרשת 22.01.202512:31 Treatment of Pleural Mesothelioma: ASCO Guideline Update ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guidelines development process as outlined in the ASCO Guidelines Methodology Manual. Journal of Clinical Oncology
מן הרשת 22.01.202512:30 Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer We report results from the exploratory concurrently randomized nivolumab plus ipilimumab and chemotherapy arms of the international phase III CheckMate 816 trial Journal of Clinical Oncology
מן הרשת 05.01.202512:20 SUO 2024: Adjuvant Systemic Therapy in Urothelial Carcinoma: Where Are We At Today? The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, TX was host to an Advanced Disease and Adjuvant Therapy session. Dr. Jean Hoffman-Censits discussed the current state of adjuvant systemic therapy for urothelial carcinoma Uro Today
תגובות אחרונות